1. Home
  2. DOW vs NTRA Comparison

DOW vs NTRA Comparison

Compare DOW & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DOW
  • NTRA
  • Stock Information
  • Founded
  • DOW 1897
  • NTRA 2003
  • Country
  • DOW United States
  • NTRA United States
  • Employees
  • DOW N/A
  • NTRA N/A
  • Industry
  • DOW Major Chemicals
  • NTRA Medical Specialities
  • Sector
  • DOW Industrials
  • NTRA Health Care
  • Exchange
  • DOW Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • DOW 27.1B
  • NTRA 22.1B
  • IPO Year
  • DOW N/A
  • NTRA 2015
  • Fundamental
  • Price
  • DOW $39.52
  • NTRA $162.31
  • Analyst Decision
  • DOW Hold
  • NTRA Strong Buy
  • Analyst Count
  • DOW 15
  • NTRA 17
  • Target Price
  • DOW $47.79
  • NTRA $165.88
  • AVG Volume (30 Days)
  • DOW 7.8M
  • NTRA 1.3M
  • Earning Date
  • DOW 01-30-2025
  • NTRA 02-27-2025
  • Dividend Yield
  • DOW 7.09%
  • NTRA N/A
  • EPS Growth
  • DOW 91.52
  • NTRA N/A
  • EPS
  • DOW 1.57
  • NTRA N/A
  • Revenue
  • DOW $42,964,000,000.00
  • NTRA $1,531,955,000.00
  • Revenue This Year
  • DOW $1.24
  • NTRA $56.11
  • Revenue Next Year
  • DOW $4.44
  • NTRA $9.76
  • P/E Ratio
  • DOW $25.19
  • NTRA N/A
  • Revenue Growth
  • DOW N/A
  • NTRA 54.94
  • 52 Week Low
  • DOW $36.66
  • NTRA $69.91
  • 52 Week High
  • DOW $60.69
  • NTRA $183.00
  • Technical
  • Relative Strength Index (RSI)
  • DOW 50.19
  • NTRA 40.88
  • Support Level
  • DOW $38.05
  • NTRA $168.15
  • Resistance Level
  • DOW $40.02
  • NTRA $180.41
  • Average True Range (ATR)
  • DOW 0.85
  • NTRA 7.08
  • MACD
  • DOW 0.17
  • NTRA -1.24
  • Stochastic Oscillator
  • DOW 83.38
  • NTRA 14.58

About DOW Dow Inc.

Dow Inc is a diversified chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a key producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets. The Company conducts its operations through six businesses, which are organized into segments, such as Packaging & Specialty Plastics, Industrial Intermediates &and Infrastructure and Performance Materials and Coatings. Packaging and Specialty.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: